| HepG2 | 
Caption: Representative image of immunoprecipitation performed on whole cell extracts from the HepG2 cell line using the ZC3H11A-specific antibody A301-524A. Lane 1: Input from IP using control IgG. Lane 2: Immunoprecipitated material using control IgG. Lane 3: Input from IP using ZC3H11A antibody. Lane 4: Immunoprecipitated material using ZC3H11A antibody. Outlined regions were excised from gel and subjected to analysis by mass spectrometry. Target molecular weight: 89.13 kDa. Method: immunoprecipitation Releated Sample: eCLIP:641 Status: Released Lab: Yeo Lab 
Caption: IP-Western Blot analysis of HepG2 whole cell lysate using ZC3H11A specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-ZC3H11A antibody (lanes under 'ZC3H11A'). Method: immunoprecipitation Releated Sample: eCLIP:641 Status: Released Lab: Yeo Lab | 
Caption: Western blot following CRISPR against ZC3H11A in HepG2 whole cell lysate using ZC3H11A specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ZC3H11A.ZC3H11A protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. Releated Sample: BGHcLV10-53 Status: Released Lab: Graveley Lab 
Caption: IP followed by mass spectrometry. Protein was immunoprecipitated from HepG2 whole cell lysates using the antibody A301-524A, loaded on a 4-12% NuPAGE Bis-Tris gel, and separated via electrophoresis. Using a reference western blot done in parallel, gel pieces corresponding to the sections indicated were excised and submitted for analysis by the UCSD Biomolecular and Proteomics Mass Spectrometry Facility. Status: Released Lab: Yeo Lab |
|---|
| K562 | 
Caption: Representative image of immunoprecipitation performed on whole cell extracts from the K562 cell line using the ZC3H11A-specific antibody A301-524A. Lane 1: Input from IP using control IgG. Lane 2: Immunoprecipitated material using control IgG. Lane 3: Input from IP using ZC3H11A antibody. Lane 4: Immunoprecipitated material using ZC3H11A antibody. Outlined regions were excised from gel and subjected to analysis by mass spectrometry. Target molecular weight: 89.13 kDa. Method: immunoprecipitation Releated Sample: eCLIP:684 Status: Released Lab: Yeo Lab 
Caption: IP-Western Blot analysis of K562 whole cell lysate using ZC3H11A specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-ZC3H11A antibody (lanes under 'ZC3H11A'). Method: immunoprecipitation Releated Sample: eCLIP:684 Status: Released Lab: Yeo Lab | 
Caption: Western blot following CRISPR against ZC3H11A in K562 whole cell lysate using ZC3H11A specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ZC3H11A. ZC3H11A protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. Releated Sample: BGKcLV11-113 Status: Released Lab: Graveley Lab
Caption: IP followed by mass spectrometry. Protein was immunoprecipitated from K562 whole cell lysates using the antibody A301-524A, loaded on a 4-12% NuPAGE Bis-Tris gel, and separated via electrophoresis. Using a reference western blot done in parallel, gel pieces corresponding to the sections indicated were excised and submitted for analysis by the UCSD Biomolecular and Proteomics Mass Spectrometry Facility. Status: Released Lab: Yeo Lab |
|---|